ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca2+/PI3-kinase/AKT signaling pathway

作者：Zhang, Yihao; Zhang, Ting; Wu, Chao; Xia, Quan; Xu, Dujuan^*

来源：Laboratory Investigation, 2017, 97(1): 53-69.

DOI：10.1038/labinvest.2016.127

• SENSING ION-CHANNEL
• P-GLYCOPROTEIN
• MULTIDRUG-RESISTANCE
• CANCER-CELLS
• TUMOR-CELLS
• EXPRESSION
• ACIDOSIS
• CALCIUM
• PI3K/AKT
• CA2+

Chemotherapy is the main treatment method of patients with advanced liver cancer. However, drug resistance is a serious problem in the treatment of hepatocellular carcinoma (HCC). Acid sensing ion channel 1 a (ASIC1a) is a H+-gated cation channel; it mediates tumor cell migration and invasion, which suggests that it is involved in the development of malignant tumors. Therefore, we studied the relationship between ASIC1a and drug resistance in human hepatocellular carcinoma. In our study, we found that ASIC1a is highly expressed in human HCC tissue, and that its levels were significantly increased in resistant HCC cells Bel7402/FU and HepG2/ADM. Inhibiting the activity of ASIC1a enhances the chemosensitivity of Bel7402/FU and HepG2/ADM cells. The overexpression of ASIC1a contributed to drug resistance in Bel7402 and HepG2 cells, whereas knockdown of ASIC1a overcame drug resistance in Bel7402/FU and HepG2/ADM cells. We further demonstrated that ASIC1a mediated calcium influx, which resulted in the activation of PI3K/AKI signaling and increased drug resistance. These data suggest that ASIC1a/Ca2+/P13K/AKT signaling represents a novel pathway that regulates drug resistance, thus offering a potential target for chemotherapy of HCC.

• 出版日期2017-1
• 单位安徽医科大学